Special Issue "Vaccine Candidates against Tropical Diseases"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against (re)emerging and Tropical Infections Diseases".
Deadline for manuscript submissions: closed (15 July 2020).
Interests: Peptide-based vaccines; peptide synthesis; synthesis of enzyme inhibitors; gene delivery; peptide conjugations; Drug design; Group A Streptococcus; Malaria; human papilloma virus; Mycobacterium tuberculosis
Tropical diseases include all diseases that occur in the tropics alone or predominantly. The term is often used in practice to refer to infectious diseases that flourish under hot humid conditions. These neglected diseases that affect a large number of populations are potentially preventable. Under conditions of deprivation, neglected tropical diseases exist and are concentrated almost exclusively in the developing world's poor communities. Due to the devastating effects of tropical diseases on the human population, they have been listed among the top diseases with high global morbidity and mortality.
Despite the great need for an effective cure, there are still no vaccines available on the market against many of these diseases. This special issue focuses on the demonstration of efforts and attempts toward the development of effective vaccine candidates against different types of tropical diseases such as malaria, hookworm infections, group A streptococcus, tick-prone diseases, dengue virus infection and other tropical diseases.
Dr. Waleed Hussein
Dr. Mariusz Skwarczynski
Prof. Istvan Toth
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccine candidates
- Group A Streptococcus
- Dengue virus
- Hookworm infection
- Tick-borne diseases